Indraneel Kanaglekar - Mar 1, 2022 Form 4 Insider Report for ZimVie Inc. (ZIMV)

Signature
/s/ Heather Kidwell, Attorney-in-Fact for Indraneel Kanaglekar
Stock symbol
ZIMV
Transactions as of
Mar 1, 2022
Transactions value $
$0
Form type
4
Date filed
3/7/2022, 06:12 PM
Previous filing
Feb 7, 2022
Next filing
Mar 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZIMV Common Stock Award +1.43K +935.95% 1.59K Mar 1, 2022 Direct F1, F2, F3
transaction ZIMV Common Stock Award +2.38K +150.35% 3.97K Mar 1, 2022 Direct F1, F3, F4
transaction ZIMV Common Stock Award +2.39K +60.28% 6.36K Mar 1, 2022 Direct F1, F3, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZIMV Stock Option (right to buy) Award +8K 8K Mar 1, 2022 Common Stock 8K $24.01 Direct F1, F6, F7
transaction ZIMV Stock Option (right to buy) Award +2.53K 2.53K Mar 1, 2022 Common Stock 2.53K $22.48 Direct F1, F6, F8
transaction ZIMV Stock Option (right to buy) Award +9.43K 9.43K Mar 1, 2022 Common Stock 9.43K $22.54 Direct F1, F6, F9
transaction ZIMV Stock Option (right to buy) Award +6.64K 6.64K Mar 1, 2022 Common Stock 6.64K $24.37 Direct F1, F6, F10
transaction ZIMV Stock Option (right to buy) Award +12.1K 12.1K Mar 1, 2022 Common Stock 12.1K $31.03 Direct F1, F6, F11
transaction ZIMV Stock Option (right to buy) Award +10.5K 10.5K Mar 1, 2022 Common Stock 10.5K $32.26 Direct F1, F6, F12
transaction ZIMV Stock Option (right to buy) Award +9.4K 9.4K Mar 1, 2022 Common Stock 9.4K $31.90 Direct F1, F6, F13
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On March 1, 2022, Zimmer Biomet Holdings, Inc. ("Zimmer Biomet") completed a pro rata spinoff distribution (the "Distribution") of shares of ZimVie Inc. ("ZimVie") common stock, par value $ 0.01 per share ("ZimVie Common Stock") to the holders of record of Zimmer Biomet common stock, par value $ 0.01 per share ("Zimmer Biomet Common Stock") on February 15, 2022. In connection with the Distribution, pursuant to the terms of the Employee Matters Agreement, dated as of March 1, 2022, between Zimmer Biomet and ZimVie (the "EMA"), all outstanding equity awards with respect to Zimmer Biomet Common Stock held by the Reporting Person were equitably adjusted and converted into equity awards with respect to ZimVie Common Stock, with such equitable adjustments determined based on (i) the volume weighted average trading price of Zimmer Biomet Common Stock on February 28, 2022 and (ii) the volume weighted average trading price of ZimVie common stock on March 1 through March 3, 2022.
F2 Represents the grant of restricted stock units with respect to ZimVie Common Stock ("ZimVie RSUs") upon the conversion of performance-based restricted stock units with respect to Zimmer Biomet Common Stock held by the Reporting Person as of March 1, 2022 in accordance with the terms of the EMA. The ZimVie RSUs vest on February 21, 2023.
F3 Reflects 153 shares of ZimVie Common Stock received in the Distribution in respect of shares of Zimmer Biomet Common Stock held by the Reporting Person as of the record date for the Distribution.
F4 Represents the grant of ZimVie RSUs upon the conversion of performance-based restricted stock units with respect to Zimmer Biomet Common Stock held by the Reporting Person as of March 1, 2022 in accordance with the terms of the EMA. The ZimVie RSUs vest on February 25, 2024.
F5 Represents the grant of ZimVie RSUs upon the conversion of restricted stock units with respect to Zimmer Biomet Common Stock held by the Reporting Person as of March 1, 2022 in accordance with the terms of the EMA. The ZimVie RSUs vest ratably in four annual installments on the first four anniversaries of the grant date, July 1, 2021.
F6 Represents the grant of stock options to purchase ZimVie Common Stock upon the conversion of stock options to purchase Zimmer Biomet Common Stock in accordance with the terms of the EMA.
F7 This option vests ratably in four annual installments on the first four anniversaries of the grant date, March 21, 2017.
F8 This option vests ratably in four annual installments on the first four anniversaries of the grant date, September 1, 2017.
F9 This option vests ratably in four annual installments on the first four anniversaries of the grant date, March 20, 2018.
F10 This option vests ratably in four annual installments on the first four anniversaries of the grant date, February 26, 2019.
F11 This option vests ratably in four annual installments on the first four anniversaries of the grant date, February 21, 2020.
F12 This option vests ratably in four annual installments on the first four anniversaries of the grant date, February 25, 2021.
F13 This option vests ratably in four annual installments on the first four anniversaries of the grant date, July 1, 2021.

Remarks:

Senior Vice President and President, Global Dental